| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 36,9 k € | +3.0% | 35,9 k € | -15.6% | 42,5 k € | -17.9% | 51,8 k € | -18.8% | 63,8 k € | -36.6% | 100,5 k € | +25.8% | 79,9 k € | -26.3% | 108,5 k € | -14.9% | 127,4 k € | +17.2% | 108,7 k € | +15.7% | 94,0 k € | +11.1% | 84,5 k € | -13.1% | 97,2 k € | -12.1% | 110,6 k € | +19.4% | 92,6 k € | +97.9% | 46,8 k € | -31.4% | 68,3 k € | +0.9% | 67,7 k € | |
| EBITDA | 34,3 k € | +3.6% | 33,1 k € | -16.8% | 39,7 k € | -19.9% | 49,6 k € | -19.6% | 61,7 k € | -35.5% | 95,7 k € | +27.6% | 75,0 k € | -27.8% | 103,9 k € | -15.0% | 122,2 k € | +17.1% | 104,3 k € | +16.4% | 89,6 k € | +11.4% | 80,4 k € | -14.6% | 94,1 k € | -12.5% | 107,6 k € | +22.4% | 87,9 k € | +104.9% | 42,9 k € | -34.4% | 65,4 k € | +1.0% | 64,7 k € | |
| Operating profit | 23,8 k € | +3.5% | 23,0 k € | +33.6% | 17,2 k € | -36.4% | 27,1 k € | -30.8% | 39,1 k € | -40.0% | 65,3 k € | +71.8% | 38,0 k € | -22.2% | 48,8 k € | -44.0% | 87,2 k € | +14.4% | 76,2 k € | +24.4% | 61,3 k € | +26.2% | 48,6 k € | -20.4% | 61,0 k € | -19.5% | 75,7 k € | +48.4% | 51,0 k € | +98.1% | 25,8 k € | -38.6% | 42,0 k € | +2.8% | 40,8 k € | |
| Profit/loss | 14,2 k € | +8.1% | 13,1 k € | +31.9% | 9,9 k € | -26.9% | 13,6 k € | -30.3% | 19,5 k € | -49.5% | 38,7 k € | +189.7% | 13,4 k € | -29.4% | 18,9 k € | -63.7% | 52,2 k € | +23.5% | 42,3 k € | +30.7% | 32,3 k € | +16.6% | 27,7 k € | -20.2% | 34,8 k € | -14.2% | 40,5 k € | +17.2% | 34,6 k € | +79.7% | 19,2 k € | -28.9% | 27,1 k € | +31.9% | 20,5 k € | |
| Equity | 253,3 k € | +5.9% | 239,2 k € | +5.8% | 226,0 k € | +4.6% | 216,1 k € | +6.7% | 202,5 k € | +33.8% | 151,4 k € | +34.3% | 112,7 k € | +13.4% | 99,3 k € | +23.5% | 80,4 k € | +185.2% | 28,2 k € | -79.4% | 136,9 k € | +30.9% | 104,6 k € | +36.1% | 76,8 k € | +82.7% | 42,0 k € | -83.3% | 251,5 k € | +15.9% | 216,9 k € | +9.7% | 197,7 k € | +15.9% | 170,6 k € | |
| Total assets | 319,9 k € | -3.5% | 331,5 k € | -4.5% | 347,3 k € | -10.6% | 388,6 k € | -9.5% | 429,5 k € | +4.2% | 412,3 k € | -4.0% | 429,5 k € | -8.4% | 468,9 k € | +17.3% | 399,6 k € | -1.3% | 405,0 k € | +0.7% | 402,0 k € | -3.3% | 415,9 k € | -4.7% | 436,6 k € | -21.2% | 554,3 k € | +28.7% | 430,7 k € | +50.1% | 287,0 k € | +0.6% | 285,4 k € | +4.1% | 274,2 k € | |
| Cash | 10,3 k € | +69.4% | 6,1 k € | -63.4% | 16,6 k € | +0.9% | 16,4 k € | -53.6% | 35,4 k € | +46.3% | 24,2 k € | +78.9% | 13,5 k € | -27.5% | 18,6 k € | -56.1% | 42,4 k € | -21.3% | 53,9 k € | +44.7% | 37,2 k € | +81.8% | 20,5 k € | +83.2% | 11,2 k € | -89.4% | 105,5 k € | +208.6% | 34,2 k € | -18.1% | 41,8 k € | +20.0% | 34,8 k € | -47.4% | 66,2 k € | |
| Debts | 65,3 k € | -28.4% | 91,1 k € | -24.0% | 119,8 k € | -30.5% | 172,5 k € | -24.0% | 227,1 k € | -13.0% | 260,9 k € | -17.7% | 316,9 k € | -14.3% | 369,6 k € | +15.8% | 319,2 k € | -15.3% | 376,8 k € | +42.1% | 265,1 k € | -14.8% | 311,3 k € | -13.5% | 359,8 k € | -29.8% | 512,2 k € | +185.9% | 179,2 k € | +155.6% | 70,1 k € | -20.1% | 87,7 k € | -15.3% | 103,6 k € | |
Private limited company · Mouscron · incorporated on 10/06/1998
Private limited company profitable and well capitalised. Cash position rising (+69.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SOCIETE DE MEDECINE XAVIER DELBERGHE is a Private limited company incorporated in 1998. Its main activity is: General medical practice activities. Its registered office is in Mouscron.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette